3 ms·
> But we can't ramp up production that quickly regardless. That is, arguably, what makes this such a bonkers decision. Given that, around the world, production
by rsynnott 6y ago
> But we can't ramp up production that quickly regardless.
That is, arguably, what makes this such a bonkers decision. Given that, around the world, production has started on phase 3 candidates, with no guarantee they'll ever be usable, skipping phase 3 doesn't really bring forward the time that a vaccine would see significant penetration. Doing so seems like a lot of risk for negligible benefit; it won't lead to saturation any quicker. And if anything goes wrong, the consequences, both immediate and in long-term damage to trust in the institutions, are potentially dramatic.
In fact, even if there are no negative medical effects, this could _still_ damage trust significantly. And raise significant ethical issues for medical professionals.